Suchergebnisse - (Subject:"Humans")

PubPharm (7.891)

1

Channeling Nicotinamide Phosphoribosyltransferase (NAMPT) to Address Life and Death

enthalten in: Journal of medicinal chemistry | 2024

von Velma, G. | Krider, I. | Alves, E. | +3

2

Targeting Myeloid Leukemia-1 in Cancer Therapy : Advances and Directions

enthalten in: Journal of medicinal chemistry | 2024

von Deng, H. | Han, Y. | Liu, L. | +5

3

Reducing PD-L1 Expression by Degraders and Downregulators as a Novel Strategy to Target the PD-1/PD-L1 Pathway

enthalten in: Journal of medicinal chemistry | 2024

von Wang, Z. | Yuan, L. | Liao, X. | +2

4

Targeting KRAS Diversity : Covalent Modulation of G12X and Beyond in Cancer Therapy

enthalten in: Journal of medicinal chemistry | 2024

von Kirschner, T. | Müller, M. | Rauh, D.

5

Research Progress of Targeted Therapy for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma --Review

enthalten in: Zhongguo shi yan xue ye xue za zhi | 2024

von Chen, D. | Wang, M. | Tian, C.

6

Pharmacology and pharmacokinetics of tazemetostat

enthalten in: Cancer chemotherapy and pharmacology | 2024

von Orleni, M. | Beumer, J.

7

TRAIL-induced apoptosis and proteasomal activity - Mechanisms, signalling and interplay

enthalten in: Biochimica et biophysica acta. Molecular cell research | 2024

von Boccellato, C. | Rehm, M.

8

Targeting RET alterations in non-small cell lung cancer

enthalten in: Current problems in cancer | 2024

von Nishikawa, G. | Klein, M.

9

MET alterations in advanced non-small cell lung cancer

enthalten in: Current problems in cancer | 2024

von Chagas, G. | Rangel, A. | El Osta, B.

10

Metabolic and toxicological considerations of Bruton's tyrosine kinase inhibitors for the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma

enthalten in: Expert opinion on drug metabolism & toxicology | 2024

von Wolska-Washer, A. | Robak, P. | Witkowska, M. | +1

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[790]